This article is more than 1 month old.

Standout Brokerage Report: Macquarie raises target price on Solara Pharma to Rs 2,112; here’s why

Mini

Macquarie has maintained an ‘outperform’ rating on Solara Pharma, raising its target price to Rs 2,112. The firm has also added the stock to the 'Asia Pacific Marquee Buy' list.

Macquarie has maintained an ‘outperform’ rating on Solara Pharma, raising its target price to Rs 2,112. The firm has also added the stock to the 'Asia Pacific Marquee Buy' list.
According to Macquarie, the key catalyst for Solara Pharma is the Vizag facility reaching its optimum utilisation in Q1 of FY22.
Watch the accompanying video of CNBC-TV18’s Nimesh Shah for more details.
To watch other videos in this series, click on the Standout Brokerage Report tab below.
Disclaimer: The views and investment tips expressed are not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

Market Movers

CompanyPriceChange%Loss
ONGC120.25 -4.85
Coal India146.40 -5.75
JSW Steel670.60 -25.75
NTPC113.55 -3.85
UPL808.00 -27.05
CompanyPriceChange%Loss
ONGC120.35 -4.65
NTPC113.55 -3.70
M&M784.85 -20.60
Power Grid Corp233.00 -6.70
Nestle17,678.30 -375.20
CompanyPriceChange%Loss
ONGC120.25 -4.85 -3.88
Coal India146.40 -5.75 -3.78
JSW Steel670.60 -25.75 -3.70
NTPC113.55 -3.85 -3.28
UPL808.00 -27.05 -3.24
CompanyPriceChange%Loss
ONGC120.35 -4.65 -3.72
NTPC113.55 -3.70 -3.16
M&M784.85 -20.60 -2.56
Power Grid Corp233.00 -6.70 -2.80
Nestle17,678.30 -375.20 -2.08

Currency

CompanyPriceChng%Chng
Dollar-Rupee73.8600-0.2175-0.29
Euro-Rupee87.8770-0.4200-0.48
Pound-Rupee102.2970-0.9290-0.90
Rupee-100 Yen0.6699-0.0019-0.29